Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era
The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-ter...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2006-05, Vol.113 (20), p.2406-2412 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2412 |
---|---|
container_issue | 20 |
container_start_page | 2406 |
container_title | Circulation (New York, N.Y.) |
container_volume | 113 |
creator | HANNAN, Edward L RACZ, Michael HOLMES, David R KING, Spencer B WALFORD, Gary AMBROSE, John A SHARMA, Samin KATZ, Stanley CLARK, Luther T JONES, Robert H |
description | The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR).
Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or > or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of > or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66).
IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge. |
doi_str_mv | 10.1161/CIRCULATIONAHA.106.612267 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67987496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67987496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMoOj_-BakP-taZtE3SPJbix2A4kO253KW3WmmbmqSC_vVGNxAhEO7N75xwDiFXjM4ZE-y2XDyXm2WxXqyeisdizqiYC5YkQh6QGeNJFmc8VYdkRilVsUyT5IScOvcWRpFKfkxOmJA0yYSakWnRj6B9ZJpIm37s0OOAzv3MI1o9eRjQTC48WjOA_YzawaP9wMG3ZogsfoDTUwe2_YLfTTidGV7iAPWRmXwwRRdEkX_FyAVzH6GFc3LUQOfwYn-fkc393bp8jJerh0VZLGPNKfcxbhmyjDc040A5SESpGpUL0JQhIM_zuuGspomoIQcldMgquYIMVM1Uk6dn5GbnO1rzPqHzVd86jV23S1UJqXKZKRFAtQO1Nc5ZbKrRtn3IWzFa_XRe_e88rEW16zxoL_efTNse6z_lvuQAXO-BUBZ0jYVBt-6Pk3ka4qr0G_Y7jzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67987496</pqid></control><display><type>article</type><title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</title><source>Journals@Ovid Complete - AutoHoldings</source><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>HANNAN, Edward L ; RACZ, Michael ; HOLMES, David R ; KING, Spencer B ; WALFORD, Gary ; AMBROSE, John A ; SHARMA, Samin ; KATZ, Stanley ; CLARK, Luther T ; JONES, Robert H</creator><creatorcontrib>HANNAN, Edward L ; RACZ, Michael ; HOLMES, David R ; KING, Spencer B ; WALFORD, Gary ; AMBROSE, John A ; SHARMA, Samin ; KATZ, Stanley ; CLARK, Luther T ; JONES, Robert H</creatorcontrib><description>The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR).
Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or > or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of > or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66).
IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.106.612267</identifier><identifier>PMID: 16702469</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Angioplasty, Balloon, Coronary ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Clinical Trials as Topic ; Coronary Disease - mortality ; Coronary Disease - surgery ; Coronary heart disease ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Female ; Heart ; Humans ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - mortality ; Myocardial Infarction - surgery ; Myocardial Revascularization - adverse effects ; Myocardial Revascularization - mortality ; Myocardial Revascularization - standards ; New York - epidemiology ; Recurrence ; Retrospective Studies ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Stents - adverse effects ; Stroke Volume ; Survival Rate ; Treatment Outcome</subject><ispartof>Circulation (New York, N.Y.), 2006-05, Vol.113 (20), p.2406-2412</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</citedby><cites>FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17835059$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16702469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HANNAN, Edward L</creatorcontrib><creatorcontrib>RACZ, Michael</creatorcontrib><creatorcontrib>HOLMES, David R</creatorcontrib><creatorcontrib>KING, Spencer B</creatorcontrib><creatorcontrib>WALFORD, Gary</creatorcontrib><creatorcontrib>AMBROSE, John A</creatorcontrib><creatorcontrib>SHARMA, Samin</creatorcontrib><creatorcontrib>KATZ, Stanley</creatorcontrib><creatorcontrib>CLARK, Luther T</creatorcontrib><creatorcontrib>JONES, Robert H</creatorcontrib><title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR).
Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or > or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of > or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66).
IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Clinical Trials as Topic</subject><subject>Coronary Disease - mortality</subject><subject>Coronary Disease - surgery</subject><subject>Coronary heart disease</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - surgery</subject><subject>Myocardial Revascularization - adverse effects</subject><subject>Myocardial Revascularization - mortality</subject><subject>Myocardial Revascularization - standards</subject><subject>New York - epidemiology</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Stents - adverse effects</subject><subject>Stroke Volume</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkN1LwzAUxYMoOj_-BakP-taZtE3SPJbix2A4kO253KW3WmmbmqSC_vVGNxAhEO7N75xwDiFXjM4ZE-y2XDyXm2WxXqyeisdizqiYC5YkQh6QGeNJFmc8VYdkRilVsUyT5IScOvcWRpFKfkxOmJA0yYSakWnRj6B9ZJpIm37s0OOAzv3MI1o9eRjQTC48WjOA_YzawaP9wMG3ZogsfoDTUwe2_YLfTTidGV7iAPWRmXwwRRdEkX_FyAVzH6GFc3LUQOfwYn-fkc393bp8jJerh0VZLGPNKfcxbhmyjDc040A5SESpGpUL0JQhIM_zuuGspomoIQcldMgquYIMVM1Uk6dn5GbnO1rzPqHzVd86jV23S1UJqXKZKRFAtQO1Nc5ZbKrRtn3IWzFa_XRe_e88rEW16zxoL_efTNse6z_lvuQAXO-BUBZ0jYVBt-6Pk3ka4qr0G_Y7jzg</recordid><startdate>20060523</startdate><enddate>20060523</enddate><creator>HANNAN, Edward L</creator><creator>RACZ, Michael</creator><creator>HOLMES, David R</creator><creator>KING, Spencer B</creator><creator>WALFORD, Gary</creator><creator>AMBROSE, John A</creator><creator>SHARMA, Samin</creator><creator>KATZ, Stanley</creator><creator>CLARK, Luther T</creator><creator>JONES, Robert H</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060523</creationdate><title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</title><author>HANNAN, Edward L ; RACZ, Michael ; HOLMES, David R ; KING, Spencer B ; WALFORD, Gary ; AMBROSE, John A ; SHARMA, Samin ; KATZ, Stanley ; CLARK, Luther T ; JONES, Robert H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-eb1e145f045a05a7ee79f986ac01eae588df51d026da8a96c732759a4a9d19f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Clinical Trials as Topic</topic><topic>Coronary Disease - mortality</topic><topic>Coronary Disease - surgery</topic><topic>Coronary heart disease</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - surgery</topic><topic>Myocardial Revascularization - adverse effects</topic><topic>Myocardial Revascularization - mortality</topic><topic>Myocardial Revascularization - standards</topic><topic>New York - epidemiology</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Stents - adverse effects</topic><topic>Stroke Volume</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HANNAN, Edward L</creatorcontrib><creatorcontrib>RACZ, Michael</creatorcontrib><creatorcontrib>HOLMES, David R</creatorcontrib><creatorcontrib>KING, Spencer B</creatorcontrib><creatorcontrib>WALFORD, Gary</creatorcontrib><creatorcontrib>AMBROSE, John A</creatorcontrib><creatorcontrib>SHARMA, Samin</creatorcontrib><creatorcontrib>KATZ, Stanley</creatorcontrib><creatorcontrib>CLARK, Luther T</creatorcontrib><creatorcontrib>JONES, Robert H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HANNAN, Edward L</au><au>RACZ, Michael</au><au>HOLMES, David R</au><au>KING, Spencer B</au><au>WALFORD, Gary</au><au>AMBROSE, John A</au><au>SHARMA, Samin</au><au>KATZ, Stanley</au><au>CLARK, Luther T</au><au>JONES, Robert H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2006-05-23</date><risdate>2006</risdate><volume>113</volume><issue>20</issue><spage>2406</spage><epage>2412</epage><pages>2406-2412</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is little information on the impact of incomplete revascularization outside of randomized trials. The objective of this study is to compare long-term mortality and subsequent revascularization for percutaneous coronary intervention patients receiving stents who were completely revascularized (CR) with those who were incompletely revascularized (IR).
Patients from New York State's Percutaneous Coronary Interventions Reporting System were subdivided into patients who were CR and IR. Then subsets of IR patients were contrasted with CR patients. Differences in long-term survival and subsequent revascularization for CR and IR patients were compared after adjustment for differences in preprocedural risk. A total of 68.9% of all stent patients with multivessel disease who were studied were IR, and 30.1% of all patients had total occlusions and/or > or =2 IR vessels. At baseline, the following patients were at higher risk: those who were older and those with more comorbid conditions, worse ejection fraction, and more renal disease and stroke. After adjustment for these baseline differences, IR patients were significantly more likely to die at any time (adjusted hazard ratio=1.15; 95% confidence interval, 1.01 to 1.30) than CR patients. IR patients with total occlusions and a total of > or =2 IR vessels were at the highest risk compared with CR patients (hazard ratio=1.36; 95% confidence interval, 1.12 to 1.66).
IR with stenting is associated with an adverse impact on long-term mortality, and consideration should be given to either achieving CR, opting for surgery, or monitoring percutaneous coronary intervention patients with IR more closely after discharge.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>16702469</pmid><doi>10.1161/CIRCULATIONAHA.106.612267</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7322 |
ispartof | Circulation (New York, N.Y.), 2006-05, Vol.113 (20), p.2406-2412 |
issn | 0009-7322 1524-4539 |
language | eng |
recordid | cdi_proquest_miscellaneous_67987496 |
source | Journals@Ovid Complete - AutoHoldings; MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Adult Aged Aged, 80 and over Angioplasty, Balloon, Coronary Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Clinical Trials as Topic Coronary Disease - mortality Coronary Disease - surgery Coronary heart disease Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Heart Humans Male Medical sciences Middle Aged Myocardial Infarction - mortality Myocardial Infarction - surgery Myocardial Revascularization - adverse effects Myocardial Revascularization - mortality Myocardial Revascularization - standards New York - epidemiology Recurrence Retrospective Studies Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Stents - adverse effects Stroke Volume Survival Rate Treatment Outcome |
title | Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T05%3A34%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20completeness%20of%20percutaneous%20coronary%20intervention%20revascularization%20on%20long-term%20outcomes%20in%20the%20stent%20era&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=HANNAN,%20Edward%20L&rft.date=2006-05-23&rft.volume=113&rft.issue=20&rft.spage=2406&rft.epage=2412&rft.pages=2406-2412&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/CIRCULATIONAHA.106.612267&rft_dat=%3Cproquest_cross%3E67987496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67987496&rft_id=info:pmid/16702469&rfr_iscdi=true |